Question

Dr. S has a patient who has recently been diagnosed with myeloma and he is discussing treatment options with the patient. Dr. S is the full-time employee of an outpatient facility run by a managed-care plan and Dr. S has recently received written instructions not to bring up subjects such as bone marrow transplantation in myeloma with patients. The reasoning was that they are outrageously expensive and do not cure the disease, although it may extend survival. The data that they extend survival are not entirely conclusive. In addition, in a private meeting with the medical director, Dr. S has been told that the expenditures per patient load of care of each of the physicians would be examined yearly to determine which physician would be promoted. What should Dr. S do? A. Give Patient treatment with melphalan or thalidomide which are both acceptable therapy B. Inform Patient about bone marrow transplantation, only if he asks about it. C C. Fully inform Patient about the risks and benefits of bone marrow transplantation. Medical coverage for indigent; especially pregnant women and children C A. Medigap C B. Medicare C. Medicaid D. Tricare The the same situation? Person Rule asks, "What would other reasonable people have done in C A. Average B. Prudent C.Responsible D. Commendable

Answer 1

1.a) give patient treatment with melphalan or thalidomide which are acceptable therapy.

Rather lately he can also inform to patient about bone marrow transplantation if patient ask. But here option a is best answer.

2.c) Medicaid

Medicaid is for medical coverage for indigent especially pregnent and children's.

3.b) prudent